Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Surprisingly, no associations were found between GLP-1 receptor agonists and breast cancer risk. People prescribed GLP-1s had a higher risk for kidney cancer compared with those receiving metformin (HR = 1.54
Distribute protein across all meals rather than concentrating it in one sitting
Peptides such as GLP1 medications and insulin are regulated by in Australia, but there has been an explosion in unapproved peptides marketed for a health, wellness and beauty outcomes
Cagrilintide is a long-acting amylin analogue, whilst retatrutide is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon pathways
In addition to obesity and diabetes, the condition GLP-1 drugs like semaglutide were initially tapped to treat, Wegovy now includes cardiovascular benefits on its label
November 14th, 2025: Three New Jersey Cases Added to Expanding GLP-1 Drug MDL A federal judicial panel has transferred three additional lawsuits from New Jersey into the growing multidistrict litigation involving claims that Eli Lilly and Novo Nordisk minimized the safety risks associated with GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Trulicity
